Does Cardinal Health's Acquisition Of Zuellig Pharma Signal China's Intent To Allow More Foreign Investment?
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. wholesaler's entry could signal the Chinese government is willing to approve foreign ownership in health care industries, such as drug distribution, that historically have been reserved for domestic players.